With the increasing use of genomic profiling for diagnosis and therapy guidance in many
tumor types, precision oncology is rapidly reshaping cancer care. However, the current …

Real-world data (RWD) and the derivations of these data into real-world evidence (RWE)
are rapidly expanding from informing healthcare decisions at the patient and health system …

The gold standard of safe-guarding the quality of published science is peer review.
However, this long-standing system has not evolved in today's digital world, where there has …

Next-generation sequencing (NGS) may enable more focused and highly personalized
cancer treatment, with the National Comprehensive Cancer Network and European Society …

Background Minimally invasive surgical approaches for gastric adenocarcinoma are
increasing in prevalence. Although recent studies suggest such approaches are associated …

Background Healthcare stakeholders have pronounced both enthusiasm and apprehension
over the expanding use of real-world evidence (RWE). The patient community—those who …

The potential for the use of real-world data (RWD) to generate real-world evidence (RWE)
that can inform clinical decision-making and health policy is increasingly recognized, albeit …

There is currently a heightened need for transparency in pharmaceutical sectors. The
inclusion of real-world (RW) evidence, in addition to clinical trial evidence, in decision …

Most of the medical practice has not been proven by controlled clinical trials, and there are
no plans to conduct such trials in order to decrease clinician uncertainty. This happens partly …

Managed care pharmacists apply real-world evidence (RWE) to support activities such as
pipeline forecasting, clinical policy development, and contracting for pharmaceutical …